2y ago The Hub
Targeted protein degradation has emerged as a revolutionary pharmacological concept that presents both viable and versatile drug development opportunities and is anticipated to introduce a new paradigm in modern healthcare London Roots Analysis has announced the addition of “Targeted Protein Degradation Market, 2021-2030” report to its list of offerings. Small-molecule-induced protein degradation has been demonstrated to possess the potential to drug a broader range of proteinaceous biological targets. It involves the selective recruitment of the body’s inherent protein degradation pathways, to eliminate disease causing / associated proteins, using bifunctional small molecule drugs. Presently, the most popular and promising class of interventions in this field of research, is proteolysis targeting chimeras (PROTACs); these can simultaneously bind a target protein and an E3-ubiquitin ligase, and thereby, facilitate the selective ubiquitination and eventual proteasome-mediated degradation of the target protein. The most interesting feature of this mechanism of drug action is the fact that PROTACs and other targeted protein degraders can eliminate protein targets regardless of their function. Access Full Report: www.rootsanalysis.com/reports/view_document/protein-degradation-market/289.html
Read More2y ago The Hub
Covid-19 Updates | Targeted Protein Degradation Enabling Technologies Market is anticipated to be worth over USD 3.3 billion by 2030
Access Full Report: www.rootsanalysis.com/reports/view_document/protein-degradation-market/289.html
2y ago The Hub
Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities of pharmacological interventions
Get Detailed Analysis: www.rootsanalysis.com/reports/view_document/digital-health-market/208.html